PROCEPT BioRobotics Corporation Current Assets
PROCEPT BioRobotics Corporation (PRCT) had Current Assets of $420.29 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-08-05
- 2026-06-30: Assets, Current $420.29M.
- 2026-03-31: Assets, Current $428.03M.
- 2025-12-31: Assets, Current $450.38M.
- 2025-09-30: Assets, Current $454.75M.
| Period end | Assets, Current |
|---|---|
| 2026-06-30 | $420.29M 10-Q · filed 2026-08-05 |
| 2026-03-31 | $428.03M 10-Q · filed 2026-04-30 |
| 2025-12-31 | $450.38M 10-Q · filed 2026-08-05 |
| 2025-09-30 | $454.75M 10-Q · filed 2025-11-05 |
| 2025-06-30 | $458.07M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $465.79M 10-Q · filed 2025-05-02 |
| 2024-12-31 | $481.84M 10-K · filed 2026-02-26 |
| 2024-09-30 | $322.98M 10-Q · filed 2024-10-28 |
| 2024-06-30 | $321.89M 10-Q · filed 2024-08-02 |
| 2024-03-31 | $329.19M 10-Q · filed 2024-05-02 |
| 2023-12-31 | $350.57M 10-K · filed 2025-02-27 |
| 2023-09-30 | $368.67M 10-Q · filed 2023-11-02 |
| 2023-06-30 | $230.02M 10-Q · filed 2023-07-28 |
| 2023-03-31 | $245.58M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $272.63M 10-K · filed 2024-02-28 |
| 2022-09-30 | $288.93M 10-Q · filed 2022-11-04 |
| 2022-06-30 | $298.34M 10-Q · filed 2022-08-05 |
| 2022-03-31 | $307.98M 10-Q · filed 2022-05-06 |
| 2021-12-31 | $326.17M 10-K · filed 2023-02-28 |
| 2021-09-30 | $339.47M 10-Q · filed 2021-11-05 |
| 2020-12-31 | $110.26M 10-K · filed 2022-03-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B |